Want to join the conversation?
Deutsche Bank analyst Abe Azar questions $NRG's strategic priorities for 2H16 beyond the GenOn restructuring. $NRG says that the company will be accelerating the GenOn restructuring, but the company is now more focused on continuing to perfect the integrated platform that it has. This goes from the Generation to Renewables to Retail Mass.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?